Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective for glycemic control and weight reduction in type 2 diabetes.
- GLP-1RAs are commonly prescribed for managing type 2 diabetes.
- They contribute to improved blood sugar levels.
- Weight loss is another significant benefit associated with GLP-1RAs.
- There is a need for further research to understand their potential effects on heart health.
Simplified